bibliographic entry 12595347 [be/12595347]
https://w3id.org/oc/corpus/be/12595347

is a

• bibliographic reference

content

• Venook, AP, Niedzwiecki, D, Lenz, H-J. CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC), ASCO Meeting Abstracts, 2014, 32, LBA3

references

• https://w3id.org/oc/corpus/br/4281923